Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(186)
•••
Comment by robertshawon Jan 06, 2020 9:52pm
144 Views
Post# 30524402

RE:RE:RE:RE:RE:RE:RE:Cup & Handle Formation or Teacup

RE:RE:RE:RE:RE:RE:RE:Cup & Handle Formation or Teacup
Quattro74 wrote:
Yep, I think if we get to .60c AND technicals look good we will see them get exercised. They won't if there is any perception price will correct back down before experation day, or even for a short period after.

CAinPlap wrote: I doubt the .54 warrants will get exercised. If you were a holder of .54 warrants and had the cash to exercise them, why would you not pay .38 now instead of .54 in about 2 months. Hope I'm wrong and there is news that propels us well above .54 before they expire.



The thing is Phillips Frost is the only holder of the 54 cents warranty, if he would rather collect the real shares now at 38 cents instead of waiting for the 54 cents to come on fruit to exercise them with pending good news coming, it will for sure generate short squeeze for the suddenly surge up of share price and volume...and the share price won't be stayed under 54 cents, so I think Phillips Frost would rather stay and wait for some more news.....
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities